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Abstract
Site-specific recombinases have become essential tools in genetics and molecular biology for the precise excision or
integration of DNA sequences. However, their utility is currently limited to circumstances where the sites recognized by the
recombinase enzyme have been introduced into the DNA being manipulated, or natural ‘pseudosites’ are already present.
Many new applications would become feasible if recombinase activity could be targeted to chosen sequences in natural
genomic DNA. Here we demonstrate efficient site-specific recombination at several sequences taken from a 1.9 kilobasepair
locus of biotechnological interest (in the bovine b-casein gene), mediated by zinc finger recombinases (ZFRs), chimaeric
enzymes with linked zinc finger (DNA recognition) and recombinase (catalytic) domains. In the "Z-sites" tested here, 22 bp
casein gene sequences are flanked by 9 bp motifs recognized by zinc finger domains. Asymmetric Z-sites were recombined
by the concomitant action of two ZFRs with different zinc finger DNA-binding specificities, and could be recombined with a
heterologous site in the presence of a third recombinase. Our results show that engineered ZFRs may be designed to
promote site-specific recombination at many natural DNA sequences.
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Introduction
The vast amount of genomic sequence data now available has led
to an increasing awareness of the far-reaching potential and
implications of ‘genomic surgery’-that is, the locus-specific insertion,
deletion or replacement of defined DNA sequences. Genomic
surgery methods could transform the treatment of genetic diseases
and lead to more sophisticated use of genetic manipulation in
biotechnology and experimental genetics. However, development of
the molecular ‘surgical instruments’ to break and rejoin DNA
strands at sequences of our choice and thus bring about desired
genetic rearrangements is still at a primitive stage [1,2]. The greatest
successes in this field to date have been achieved with zinc finger
nucleases (ZFNs), which comprise an endonuclease domain fused to
a zinc finger DNA-binding domain. ZFN heterodimers can
introduce a double-strand break (DSB) at targets with appropriately
spaced binding sites for two different zinc finger domains [3,4],
potentially leading to high-frequency homologous recombination or
mutagenic DNA repair at the target locus. Current advanced
methods for creation of altered-specificity zinc finger domains [4]
allow ZFNs to be designed to target a wide range of natural
sequences. However, finalization of the desired genetic changes
requires repair or recombination at the ZFN-induced DSB
mediated by endogenous enzymes. Inefficient or aberrant operation
of these processes often results in low levels of gene modification or
undesired sequence changes [5]. Similar limitations apply to the use
of all other agents that simply introduce site-specific DSBs.
In contrast, site-specific recombinases possess all the enzyme
functions required to bring about efficient, precise integration,
deletion or inversion of defined DNA segments [6], and might be
very effective instruments for genomic surgery if their target
specificity could be altered at will [1]. Already, directed evolution
methods have been applied to create recombinase variants with
activity at certain genomic sites which bear some resemblance to
the target site of the original recombinase [7,8]. However, a more
incisive strategy is to create zinc finger recombinases (ZFRs)
analogous to ZFNs, which could be re-targeted by changing the
DNA recognition specificity of the zinc finger domains. Serine
recombinases of the resolvase-invertase group, such as the well
characterized Tn3 and cd resolvases and the Hin and Gin
invertases, are especially attractive as starting points for this
approach because of their modular structure, with autonomous
catalytic and DNA-binding domains (Figure 1A) [6]. The catalytic
domains of these recombinases might therefore be predicted to
function when linked to different (zinc finger) DNA-binding
domains. However, recombination activity by natural serine
resolvases and invertases is strictly dependent on the presence of
complex regulatory DNA sequences containing binding sites for
extra recombinase subunits and/or accessory proteins [6], and the
natural catalytic domains are inactive in the absence of these
features. The development of ZFRs was only feasible following the
isolation of ‘activated’ recombinase mutants which do not require
any accessory factors, and recombine short dimer-binding sites [9–
12]. In previous work from this laboratory, ZFRs (previously called
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Z-resolvases) were made by linking the catalytic domain of a Tn3
resolvase activated mutant to a zinc finger (Zif268) DNA-binding
domain. These ZFRs promote efficient recombination at Z-sites
(Figure 1B), which have a central sequence acted upon by the
catalytic domains (optimally 22 bp), immediately flanked by 9 bp
motifs recognized by the Zif268 domains [13]. ZFRs, like ZFNs,
have the potential to target many new sequences, being limited in
principle only by the range of sequences for which specific zinc
finger domains can be made and by the sequence selectivity of the
catalytic domain [1]. Many natural serine recombinases with
distinct sequence specificities are known [14], and their catalytic
domains could be co-opted to make ZFRs if suitable activated
mutants were available [1]. ZFRs with catalytic domains from Tn3
resolvase and Gin invertase have been demonstrated to be active
in human cell lines [15,16], illustrating the potential applicability
of these enzymes in mammals and other eukaryotic organisms.
The Tn3/cd resolvase catalytic domains contact the recombi-
nation crossover site (site I) in the minor groove over about 12 bp
(Figure 1A) [17,18]. Some mutations of this 12 bp sequence
strongly inhibit recombination, whereas others do not [19]. The
structural basis for this partial specificity and the consensus
sequence for the resolvase catalytic domain are still unclear. In our
earlier experiments with ZFRs the Z-site central sequence was
similar to that of site I, to optimize catalytic domain interactions
[13]. However, the specificity of the catalytic domain would need
to be altered or reduced in order to target most natural sequences
which do not resemble site I. Here, we prove the wide applicability
of ZFRs by showing that a number of sequences within a short
(,2 kbp) genomic locus of biotechnological interest are suitable as
recombination targets for ZFRs with evolved broad specificity
catalytic domains. Furthermore, pairs of evolved ZFRs with
different DNA-binding specificities can cooperate to recombine
asymmetric Z-sites, and, in a model for targeted gene integration,
an asymmetric Z-site can recombine with a partner site that binds
a third recombinase. Our results highlight the great potential of
ZFRs as next-generation tools for genomic surgery.
Materials and Methods
ZFR expression plasmids and recombination substrate
plasmids
Expression plasmids for ZFRs or the NM variant of Tn3
resolvase [10] were of two types. Plasmids with a pBR322 origin of
replication (pbZFR) were similar in construction to those
previously described [13]. A resolvase expression plasmid with a
p15a origin of replication (pEK76) was derived from pACYC184
[20], by insertion of an SspI-EcoRV resolvase-encoding fragment
from pAT5 [21] into the pACYC184 AvaI site. ZFR expression
plasmids (paZFR) were then created by insertion of ORF-
containing fragments between unique NdeI and Asp718 sites in
pEK76. In order to allow simultaneous expression of three
recombinases in an E. coli strain, two further expression plasmids
paZFRAB320 and pbZFRAB320 were made, which have the
reading frames and translational start signals for ZFRA320 and
ZFRB320 (described in the Results section) in tandem.
The ‘progenitor’ ZFR used here (ZFR300) consists of the Tn3
resolvase catalytic domain (residues 1–148) containing the seven
mutations R2A E56K G101S D102Y M103I Q105L V107F,
followed by the 2-amino acid linker TS, then the Zif268 DNA-
binding domain starting at residue E2 (ERPY...). The codons for
the TS linker introduce a unique SpeI restriction site. Some of the
reasoning behind the design of the ZFR300 amino acid sequence
has been reported [13]; further details will be described elsewhere
(M. Prorocic et al., unpublished). Mutations in the Zif268 domain
of ZFR300 were introduced by cloning oligonucleotides between
appropriate restriction sites in a pbZFR plasmid.
The sequences of the Z-sites used here are shown in Figure 2B.
Recombination substrate plasmids, with two Z-sites flanking a galK
marker gene, were analogous to those described [13]. Full details
of the plasmid constructions and sequences are available on
request.
Mutagenesis, and construction of mutant libraries
The entire ZFR reading frame in pbZFR300 (or variants
thereof) was mutagenized by PCR with the addition of modified
dNTPs, as described [10]. The primers were 22F (59-CGC-
CAGGGTTTTCCCAGTCACG-39) and 23R (59-TCACACAG-
GAAACAGCTATGACC-39), and either dPTP or d(8-oxoG)TP
[22] was added at 10% of the total dNTP concentration. A sample
of the PCR product was re-amplified without mutagenic dNTPs,
so that the DNA fragments to be cloned did not contain unnatural
bases. Following purification, the cleaned-up PCR product was
digested with NdeI and SpeI, and the 447 bp mutagenized
fragment (encoding the resolvase catalytic domain) was ligated to
the NdeI-SpeI vector fragment of pbZFR300. Libraries of mutant
expression plasmids (library size ,105) were created by transfor-
mation of competent E. coli DS941 cells with the ligation products
and preparation of plasmid DNA from colonies on agar plates, as
described [10].
Recombination assays, screening libraries and isolation of
mutants
E. coli colony colour assays of recombination were as described
[13]; briefly, transformants were selected on MacConkey-galactose
indicator plates (MacConkey agar base (Difco) supplemented with
Figure 1. Design of ZFRs, Z-sites and test substrates. (A) Cartoon
showing a Tn3 resolvase dimer bound to res site I. The red ovals
represent the N-terminal (catalytic) and C-terminal (DNA-binding)
domains. The motifs recognized by the C-terminal domains are yellow,
and the central 12 bp segment (pink) is contacted by the catalytic
domains.(B) Cartoon showing a ZFR dimer bound to a Z-site. The zinc
finger domains are blue, the motifs they recognize are pale blue, and
the ZFR linker peptide is green. Other features are as in A.
doi:10.1371/journal.pone.0019537.g001
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1% galactose, kanamycin (to select for the substrate plasmid or its
resolution product), and ampicillin (to select for pbZFR expression
plasmids) and/or chloramphenicol (to select for paZFR expression
plasmids). Pale coloured (galK¯) colonies indicate recombination
(resolution) proficiency, whereas red (galK+) colonies indicate lack
of resolution.
To screen for recombination-proficient ZFR mutants, DS941
cells containing a recombination substrate plasmid were trans-
formed with a library of mutant expression plasmids. Aliquots of
the transformants were selected on MacConkey plates (aiming for
,1000 colonies per plate; 30–60 plates). Pale-coloured colonies
were picked and were streaked on MacConkey plates to confirm
the colony colour. Plasmid DNA purified from positive isolates was
used to transform the same DS941-substrate plasmid strain. If the
transformant colonies on MacConkey plates were all pale-
coloured, the ZFR was deemed to be a recombination-proficient
mutant, so the expression plasmid was isolated and the ZFR
reading frame was sequenced.
To analyse the DNA products of recombination, strains
containing a substrate plasmid were transformed with a ZFR
expression plasmid or, for experiments with two or three
recombinases, co-transformed with two expression plasmids
having compatible origins of replication (paZFR and pbZFR;
see above). Transformants were grown with appropriate antibiotic
selection on L-agar plates. Following incubation at 37uC, cells
were washed from the plates with L-broth, and plasmid DNA was
purified from the cells using a Qiagen miniprep kit. The DNA was
visualized by ethidium staining after 1.2% agarose gel electropho-
resis. To quantify the extent of recombination (leading to deletion
of the galK gene) more accurately, the recovered plasmid DNA was
used to transform the strain DS941, test plasmid-containing
transformants were selected on MacConkey agar plates with
kanamycin, and the percentage of pale (galK¯) colonies (from a total
of .100) was determined. In Figures 3, 4, and 5, a value of 0
indicates that all colonies were red (galK+), 100 indicates that all
were pale, and,1 (or.99) indicates that there were a few pale (or
red) colonies.
Results
Experimental design
The 1930 bp first intron of the bovine b-casein gene was chosen
as a target locus with potential biotechnological utility; a transgene
integrated at this locus could be regulated by the b-casein
promoter, giving high-level expression of a transgenic protein in
milk. Our aim here was to identify sequences within this intron
that would be suitable targets for ZFR-mediated integration.
Analysis of the intron sequence revealed 17 occurrences of the
TATA motif which is found at the centre of Tn3 res site I, and
which might be optimal for resolvase activity [19] (Figure 2A). Six
of these potential target sequences that were most similar to site I
over the 12 bp centred on the TATA motif (with at least 8 out of
12 basepairs identical in one orientation; Figure 2A) were selected
for further analysis. ‘ZcasZ’ sites were made, each comprising
22 bp of a casein gene intron sequence flanked by 9 bp motifs
recognized by the Zif268 zinc finger domain (Figure 2B). A control
Ztn3Z site with Tn3 res site I central sequence was also made.
Plasmids were then constructed in which two identical Z-sites are
separated by a galK marker gene (Figure 2C). If ZFR-mediated
recombination (resolution) in E. coli cells deletes galK, the colonies
on MacConkey-galactose indicator plates are pale, whereas galK+
colonies are red [10]. ZFR-mediated recombination can also result
in inversion of the orientation of the galK segment, but this
outcome is not detected by the assays used here.
Selection of active ZFR variants
We began by analysing recombination of the substrates by an
already available ZFR. ZFR300 consists of the catalytic domain of
an activated Tn3 resolvase variant, linked to the Zif268 zinc finger
DNA-binding domain (see Materials and Methods). E. coli cells
containing a substrate plasmid were transformed with a ZFR300
expression plasmid. Recombination activity was detected by
colony colour on MacConkey indicator plates, and then by
electrophoretic analysis of plasmid DNA recovered from the
cultured cells. The Ztn3Z substrate was resolved completely by
ZFR300, as expected. Encouragingly, two of the six ZcasZ
substrates were also recombined; Zcas1Z (complete resolution) and
Zcas4Z (incomplete resolution) (Figure 3A).
To find ZFR variants that would promote recombination at the
four refractory ZcasZ sites, we subjected the entire catalytic domain
to random mutagenesis using two error-prone PCR protocols, and
made libraries of plasmids expressing mutant ZFRs. Screens of the
libraries using Zcas2Z and Zcas5Z substrate plasmids yielded
several active mutants (Table 1), whereas no mutants were
recovered from screens with the Zcas3Z and Zcas6Z plasmids.
Recovery of DNA from the cells showed that one mutant (ZFR310)
with the single conservative change I77L had significant recombi-
nation activity on all six ZcasZ substrates, although Zcas3Z and
Zcas6Z substrates still gave only red colonies (Figure 3B).
The mutagenesis-screening procedure was then repeated, using
ZFR310 as the template for mutagenesis, and the Zcas6Z test
substrate (which gave the lowest level of recombination with
ZFR310). Several active mutants were isolated which were shown to
promote efficient recombination of the Ztn3Z and all six ZcasZ test
substrates (Table 2; illustrated for the double mutant I77L E132A
(ZFR320) in Figure 3C). The mutations thus broaden rather than
switch specificity. However, selectivity is not completely abolished,
and the mutants do not recombine some Z-sites with central
sequences that are very unlike site I. For example, ZFR320 did not
recombine a Z-site with the central sequence of the recombination
site for Sin resolvase [23] (data not shown).
Figure 2. Casein gene sequences, Z-sites, and recombination assay. (A) Tn3 res site I (top line) and the seventeen TATA-containing
sequences from the b-casein gene intron 1 (Genbank accession number X14711), aligned with the central TATA of site I. Sequences are numbered
from the start of exon 1. The motifs in site I bound by the resolvase C-terminal domains are highlighted in yellow. Bases identical to site I within the
central 12 bp of the casein sequences are highlighted in pink. The column on the right gives the number of bases identical to the central 12 bp of
site I (the number before the slash is for the alignment shown, and the number after the slash is for the sequence aligned in the opposite orientation).
The six ‘cas’ sequences, whose central 22 bp sequences were used in the recombination sites analysed in this study, are indicated. The 9 bp
sequences flanking the central 22 bp are also shown (highlighted in blue); these sequences would be bound by the ZFR zinc finger domains if the
genomic casein gene sequences were to be targeted as Z-sites (see Figure 1B). (B) Sequences of site I and Z-sites. The Z-site motifs recognized by the
Zif268 domains are highlighted pale blue. The central 22 bp sequences of the ZcasZ sites are from the casein gene sequences shown in part A.
Identities of the sequences to the central 12 bp of site I are highlighted pink. Note that the ZcasZ sequences are aligned here to maximize their
matches with site I, so some are in the opposite orientation from part A. Motifs recognized by mutant Zif268 domains ZifA and ZifB are highlighted in
magenta and cyan respectively. See text for further details. (C) Z-site substrate plasmids and colony colour assay. Recombination between the two
Z-sites (boxes) deletes the galK gene, causing colonies to be pale rather than red on MacConkey-galactose indicator plates.
doi:10.1371/journal.pone.0019537.g002
Zinc Finger Recombinases
PLoS ONE | www.plosone.org 4 April 2011 | Volume 6 | Issue 4 | e19537
Recombination of asymmetric Z-sites mediated by pairs
of ZFRs
Next, we demonstrated that ZFR activity can be targeted to
different Z-sites by substitution of the Zif268 zinc finger domain
with altered-specificity variants. The ZFR300-coding sequence
was modified so as to replace the Zif268 domain with ZifA or ZifB,
synthetic variants with published sequences and target sites
(Figure 2B) [24]. The resulting recombinases ZFRA300 and
ZFRB300 were tested along with ZFR300, on substrate plasmids
with pairs of Ztn3Z, Atn3A, or Btn3B Z-sites (the sites are shown
in Figure 2B). Each substrate was recombined by the ZFR whose
zinc finger domain was specific for the Z-site sequences, but not by
the ZFRs with different specificity (Figure 4A).
Targeting of a natural asymmetric sequence (such as the chosen
casein gene sequences) would require two ZFRs which would
interact on the site to form a heterodimer, one ZFR binding to
each end of the site. Previous work from our laboratory showed
that activated resolvase mutants assemble DNA-bound dimers and
synaptic tetramers from solution monomers [11], so we predicted
that ZFRs would behave similarly and readily form DNA-bound
heterodimers. We made test substrates with pairs of Atn3B or
AcasB Z-sites (each of these sites has one motif recognized by ZifA
and one by ZifB; Figure 2B). To test for recombination, an E. coli
strain containing a substrate was transformed with two compatible
plasmids, each expressing one ZFR variant. Efficient recombina-
tion of the Atn3B substrate was observed only in the presence of
both ZFRA300 and ZFRB300 (Figure 4B). The AcasB substrates
were tested with ZFRA320 and ZFRB320, which have the
broadest-specificity evolved catalytic domain. All the substrates
were recombined when both ZFRA320 and ZFRB320 were
expressed; the extent of recombination (i.e. resolution of the test
plasmid) ranged from 100% (Acas1B) down to 8% (Acas6B)
(Figure 4C).
ZFR-mediated recombination between non-identical
sites
For transgene integration at any chosen genomic locus, only
one of the recombining sites (the genomic one) must be targeted
by ‘designer’ ZFRs. The other site (on the transgenic DNA)
could be acted on by any recombinase with a compatible
catalytic domain, and could be optimized for integration
efficiency and specificity. To model this scenario, we made
substrates with non-identical pairs of sites. The Ztn3Z site
contains at its centre 22 bp of the natural target sequence for our
ZFR catalytic domains (Tn3 res site I), and a substrate with two
of these sites is therefore recombined efficiently (Figure 3A). To
analyse recombination between Ztn3Z and each of the ZcasZ
sites, we made a set of six ZcasZ6Ztn3Z substrate plasmids.
These plasmids were recombined more efficiently than the
corresponding ZcasZ6ZcasZ plasmids; in fact, the ‘first round’
mutant ZFR310 (with the single mutation I77L) resolved all of
them (Figure 5A), whereas it had failed to resolve the plasmids
with pairs of Zcas3Z or Zcas6Z sites (Figure 3B). Then, in order
to show that the partner site need not be a Z-site, we made
substrates which contained a ZcasZ site paired with Tn3 res site
I. Recombination of all six ZcasZ6site I substrates was efficient
when both an activated Tn3 resolvase variant (NM resolvase;
[11]) and a ZFR (ZFR310) were co-expressed (Figure 5B),
whereas NM resolvase alone or ZFR310 alone did not promote
recombination (data not shown).
Finally, we tested a substrate designed to model transgene
integration as outlined above, where one "genomic" recombina-
tion site is targeted by the combined action of two designer ZFRs,
and the other "transgene" site is recognized by a third
recombinase. For the "genomic" site we chose to use Acas6B, in
which the least reactive casein sequence is flanked by motifs
recognized by engineered variant ZifA and ZifB domains. The
sequence of the Acas6B site is quite unlike that of the natural
targets of either Tn3 resolvase or Zif268. For the "transgene" site
we used Tn3 res site I, as in the experiments described above. The
substrate is cartooned in Figure 5C. Acas6B6site I recombination
required the expression of NM resolvase and ZFRs, and was most
efficient when ZFRA320, ZFRB320, and NM resolvase were all
present (Figure 5C), although significant recombination also
occurred when either one of the ZFR proteins and NM resolvase
were co-expressed.
Figure 3. Selection of ZFRs to recombine casein gene sequences.
(A) Activity of the progenitor ZFR (ZFR300) on Z-sites with central
sequences from Tn3 res site I or the casein gene intron 1. The substrate
plasmids each contained two identical Z-sites as indicated above the gel
lanes. The numbers below each lane represent the percentage of
recombinant plasmids in the recovered DNA (see Materials and
Methods). Images of the ethidium-stained gels are greyscale-inverted,
and a uniform background subtraction has been applied. A representa-
tive sector of a plate from the corresponding MacConkey-galactose assay
is shown above each lane. Annotation: exp, ZFR expression plasmid; nr,
non-recombinant substrate plasmid; rec, recombinant (galK2) plasmid.
(B) Activity of the first round mutant I77L (ZFR310) on the same
substrates as in A. (C) Activity of the second round double mutant I77L
E132A (ZFR320) on the same substrates as in A.
doi:10.1371/journal.pone.0019537.g003
Zinc Finger Recombinases
PLoS ONE | www.plosone.org 5 April 2011 | Volume 6 | Issue 4 | e19537
Figure 4. Recombination of asymmetric Z-sites. (A) Altered-specificity zinc finger domains target ZFRs to their cognate Z-sites. Substrates
containing two identical Z-sites, with either A, B, or Z flanking motifs (Atn3A, Btn3B, Ztn3Z; Figure 2B), were recombined by ZFR300 variants with
alternative zinc finger domains as indicated immediately above each lane. (B) Efficient recombination at asymmetric (Atn3B) Z-sites requires two
ZFR300 variants, with ZifA and ZifB specificity. The letters above each lane indicate the binding domains borne by the expressed ZFRs, with specificity
for either Zif268 (Z), ZifA (A), or ZifB (B) motifs. exp(a), pACYC184-based ZFR expression plasmid (paZFR); exp(b), pBR322-based ZFR expression
plasmid (pbZFR). (C) Efficient recombination of AcasB site substrates requires co-expression of ZFRA320 and ZFRB320.
doi:10.1371/journal.pone.0019537.g004
Figure 5. Recombination between non-identical sites. (A) Substrates containing a Ztn3Z site and a ZcasZ site are recombined by ZFR310. The
annotation is as in the previous Figures. The band marked with an asterisk is thought to be single-stranded expression plasmid DNA. (B) Substrates
containing a ZcasZ site and Tn3 res site I are recombined when ZFR310 and NM resolvase are co-expressed. (C) A substrate containing an Acas6B site
and Tn3 res site I is recombined most efficiently when NM resolvase, ZFRA320 and ZFRB320 are co-expressed.
doi:10.1371/journal.pone.0019537.g005
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Discussion
Ideally, if ZFRs are to become widely applicable, recombination
activity should be insensitive to the central sequences of the target
Z-sites, which interact with the recombinase catalytic domains. A
useful comparison may be made with the zinc finger nucleases
(ZFNs), whose catalytic domain (from the FokI restriction
endonuclease) has low sequence selectivity. However, it is clear
that natural serine recombinase catalytic domains contribute
significantly to DNA sequence specificity; for example (as noted
above), recombination by cd resolvase is strongly inhibited by
some mutations of the target site for its catalytic domains [19].
When we began this project, it was not clear whether the
specificity of the resolvase catalytic domain could be reduced to
the point where a substantial number of genomic sequences could
be targeted effectively. Recently, mutant ZFRs with Tn3 resolvase-
and Gin-derived catalytic domains were shown to promote
recombination at some specific non-canonical target sequences
[25].
We chose the bovine b-casein gene intron as a potential
recombinase target because of the potential biotechnology utility
of integration at this locus, not because it was known to contain
any sequence resembling a natural recombination site. Six
sequences from the 1.9 kbp intron were inserted into Z-sites and
Table 2. Mutant ZFRs selected for recombination of Zcas6Z sites.
Z Site
2nd Round Mutations No. Ztn3Z Zcas1Z Zcas2Z Zcas3Z Zcas4Z Zcas5Z Zcas6Z
ZFR310 W W W R W W R
N31D M53R N127K 1 W W W W W W W
I3P V108A 1 W W W W W W W
L135R 2 W W W W W W W
S12R D17E 1 W W W W W W W
S12R I103V 1 W W W W W W W
E132A (ZFR320) 5 W W W W W W W
I3L L135R 1 W W W W W W W
I3S E132A 1 W W W W W W W
N127H E132A 1 W W W W W W W
I3S D25A F83L 1 W W W W W W W
The Table shows the ‘second round’ mutants isolated from screens of ZFR310 mutant libraries (ZFR310 is ZFR300 with the mutation I77L), using a test substrate
containing two Zcas6Z sites. The left-hand column gives the mutations, and the next column indicates the number of independent isolates. The other columns show
the phenotype of each mutant in the MacConkey agar colony colour assay, using substrates with two identical ZcasZ sites as indicated. W, ‘white’ (pale-coloured)
colonies; R, red colonies; M, mixtures of pale and red colonies.
doi:10.1371/journal.pone.0019537.t002
Table 1. Mutant ZFRs selected for recombination of Zcas2Z or Zcas5Z sites.
Z Site
z1st Round Mutations No. Ztn3Z Zcas1Z Zcas2Z Zcas3Z Zcas4Z Zcas5Z Zcas6Z
ZFR300 W W R R R R R
I77L (ZFR310) 8 W W W R W W R
F83L F107L 3 W W R R W R R
I3T D95E 1 W W M R W M R
G70S F107L 1 W W M R W W R
E57G A89V 1 W W W R W R R
K37R D44N 1 W W W R W W R
I97V I103T F107L 1 W W W R W W M
G70S / n.d. W R R M R R
F107L / n.d. W R R W R R
E57G / n.d. W R R R R R
A89V / n.d. W R R W R R
The Table shows mutants isolated from libraries of mutagenized ZFR300. The left-hand column gives the mutations, and the next column indicates the number of
independent isolates. The other columns show the phenotype of each mutant in the MacConkey agar colony colour assay, using substrates with two identical ZcasZ
sites as indicated. W, ‘white’ (pale-coloured) colonies; R, red colonies; M, mixtures of pale and red colonies. The letters in bold show the ZcasZ substrate (Zcas2Z and/or
Zcas5Z) that was used in the screen from which the mutant was isolated. The four point mutants shown below the thick line were isolated by cloning appropriate
fragments from the originally isolated multiple mutant (above the line). n.d., not done.
doi:10.1371/journal.pone.0019537.t001
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shown to be recombined efficiently by ZFRs with evolved Tn3
resolvase-derived catalytic domains. However, many more se-
quences in the intron might also be suitable for ZFR-mediated
recombination. All the chosen sequences had a central TATA
motif like Tn3 res site I, and there are 11 more of these in the
intron (Figure 2A), but a central TATA is not essential for
resolvase activity [19]; 98 other sequences are identical to site I at
8 or more positions of the central 12 bp, and many of these might
also support recombination. The range of potential target Z-sites
might be extended even further by making ZFRs based on
catalytic domains from other serine recombinases with different
specificities [1,14]. Many other important genomic loci are likely
to be similarly rich in potential Z-sites.
To promote recombination at a typical asymmetric genomic Z-
site, two ZFRs might be expected to be required, each with a
‘designer’ zinc finger domain to recognize one end of the site. An
optimal site would therefore have left and right ends suitable for
binding by engineered zinc finger domains. However, our
experiments show that in some cases, recombination activity at
an asymmetric Z-site can be elicited by the expression of only one
ZFR (Figure 4C, 5C). We hypothesize that a single ZFR subunit
bound to its cognate DNA sequence can recruit a second "non-
specific" ZFR subunit to the Z-site by dimerization of the catalytic
domains. In general, this phenomenon is undesirable, as it could
reduce the achievable sequence specificity of ZFRs. A related
phenomenon is evident in the recombination reactions involving
two or three recombinases (Figures 4 and 5), which were generally
not as efficient as those involving only one type of ZFR. We
suspect that this reduced efficiency is because inappropriate
recombinase dimers can bind to recombination sites and block
recombination. For example, the two recombinases used in the
experiment shown in Figure 4C (ZFRA320 and ZFRB320) can
assemble into three different types of dimer (homodimers of
ZFRA320 and ZFRB320, and ZFRA320-ZFRB320 heterodimer).
Only the heterodimer matches the AcasB recombination site, but
the homodimers can nevertheless bind to the site as they can
recognize the DNA sequence at one end. The scenario with three
recombinases, as in Figure 5C, is even more complex. ZFNs,
which also recognize asymmetric sites as heterodimers, show
similar losses of specificity and efficiency due to homodimerization.
The problem has been addressed by introducing mutations in the
ZFN catalytic domain that favour on-site formation of the desired
heterodimers [26], and a similar approach should be applicable to
ZFRs. In other respects, ZFRs could be at least as specific for their
targets as ZFNs; in fact, ZFRs might have especially high
specificity due to their requirement for synapsis of two sites prior
to recombination.
Another feature of our experimental results which should be
noted is that the total amount of substrate plasmid and its
recombinant product is reduced in the presence of some ZFR
variants; see, for example, Figures 3C and 4C. It is possible that
some of the plasmid is being lost due to a ZFR activity at the Z-
sites (for example, incomplete recombination leading to formation
of double-strand breaks, a known property of activated mutant
recombinases [11]). Further experiments are necessary to ascertain
the causes of this "loss of plasmid" effect and to find ways of
minimizing any undesirable outcomes of ZFR activity.
Surprisingly, the first round of selection of ZFR mutants for
activity on ZcasZ sites did not yield any mutations of residues that
contact or are close to the DNA [17,18] (Table 1), but some
mutations (including I77L) were of residues that we had previously
identified as being important for regulation of resolvase’s catalytic
activity [10]. These mutations might therefore broaden sequence
specificity by relaxing the stringency of a regulatory mechanism.
However, the second-round mutations (additional to I77L) were of
a different set of residues, some of which have sidechains that
come close to the DNA where the C-terminal end of the catalytic
domain is embedded in the minor groove [17]. The two most
commonly isolated mutations, E132A and L135R (Table 2), both
increase the positive charge of this part of the protein, perhaps thus
increasing its general affinity for negatively charged DNA.
Two general types of designer ZFRs may be envisaged; one
type, with evolved low-specificity catalytic domains, is reported
here, and is likely to be the most accessible for applications in the
immediate future. Alternatively, catalytic domains tailored for
high-specificity recognition of a Z-site central sequence might be
desirable for applications where it is essential to minimize off-
target reactions, such as gene therapy. Successful implementation
of this strategy will be more challenging, as it will demand a
thorough understanding (currently lacking) of the structural basis
for DNA sequence recognition by the catalytic domain. A very
recent paper [27] describes progress on this front; the specificities
of ZFRs derived from Tn3 resolvase and Gin invertase were
partially switched towards activity on Z-sites with the other’s
central sequence, by mutagenesis of catalytic domain residues in
the C-terminal region of the protein that contacts the DNA minor
groove. Only one of the six residues chosen for mutagenesis by this
group was also identified in our analysis; N127 (Table 2). The set
of residues which can be mutated to broaden specificity might
therefore not coincide with the set of residues which detect
differences in DNA sequence.
ZFRs could be used to promote transgene integration at a
specific locus, or deletion of specific genomic DNA segments. In
the general case, deletion between two different, asymmetric sites
might require up to four ZFRs, each with DNA-binding specificity
for one half-site. However, one very attractive potential applica-
tion for designer recombinases is to delete the integrated proviral
DNA of retroviruses such as HIV by recombination between
identical sequences in the Long Terminal Repeats (LTRs) that
flank the provirus [8], and this would require only two ZFRs.
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